Patent Purchasing Agreement and Backlicense Agreement between Productomics AG, Promenade 132 A, CH-7260 Davos-Dorf, SwitzerlandPatent Purchasing Agreement and Backlicense Agreement • September 1st, 2006 • Imvision Therapeutics Inc.
Contract Type FiledSeptember 1st, 2006 CompanyThe Seller is hereby granted all rights of registration of patents GB 0309345.7 and WO 2004/094639 A2 entitled “A recombinant Allergen”, requiring the use of the Fel d1 recombined allergen (fusion molecule in field 1 chain 2 and chain 1) in the diagnosis and treatment of cat allergies.